Entourage effect
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Goonsquad LCpl Mulvaney (talk | contribs) at 20:01, 26 November 2016 ({{cannabis-stub}}). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 20:01, 26 November 2016 by Goonsquad LCpl Mulvaney (talk | contribs) ({{cannabis-stub}})
 | This article provides insufficient context for those unfamiliar with the subject. Please help improve the article by providing more context for the reader. (October 2014) (Learn how and when to remove this message) |
Entourage effect is a phrase that was introduced in cannabinoid science in 1998 by S. Ben-Shabat, with Raphael Mechoulam, to represent a novel endogenous cannabinoid molecular regulation route. Biological activity assayed together with inactive compounds. References whole plant and whole person caregiver synergy treatments over isolated compound pharmacological dosages.[1][2][3][4][5][6][7][8]
External links
References
- ^ Lee, Martin A. (Sep 13, 2013). Smoke Signals: A Social History of Marijuana-Medical, Recreational and Scientific. Scribner. p. 465. ISBN 978-1439102619.
- ^ Ben-Shabat, Shimon (July 17, 1998). "An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity". European Journal of Pharmacology. 353 (1): 23–31. doi:10.1016/S0014-2999(98)00392-6.
- ^ Andersson, Karl-Erik (Feb 4, 2011). Urinary Tract. eBook: Springer Science & Business Media. p. 438.
- ^ Newnes (March 5, 2010). Comprehensive Natural Products II: Chemistry and Biology:. eBook: Google. p. 220.
- ^ Guy, Geoffrey William (July 1, 2004). The Medicinal Uses of Cannabis and Cannabinoids (1st ed.). Pharmaceutical Press. p. 114. ISBN 978-0853695172.
- ^ Castle, David (May 27, 2004). Marijuana and Madness: Psychiatry and Neurobiology. eBook: Google. p. 8.
- ^ Russo, Ethan B (Aug 2011). "Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects". Br J Pharmacol. 163 (7): 1344–1364. doi:10.1111/j.1476-5381.2011.01238.x. PMC 3165946. PMID 21749363.
- ^ Gardner, Fred (2011). "Terpenoids, 'minor' cannabinoids contribute to 'entourage effect' of Cannabis-based medicines". The Journal of Cannavis in Clinical Practice: 1.
| Receptor (ligands) |
| ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transporter (modulators) |
| ||||||||||||||||||||||||||||||
| Enzyme (modulators) |
| ||||||||||||||||||||||||||||||
| Others |
| ||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
